Tvardi Therapeutics Inc. (TVRD)
NASDAQ: TVRDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 12:58 PM ET
TVRD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $14.01M
- EPS (TTM)
- -$2.84
- Dividend yield
- None
- 52-week range
- 0.93 – 43.65
- Day range
- 1.04 – 1.10
- Volume / Avg
- 57.29K / 538.92K
- Beta
- —
- Shares outstanding
- 13.34M
52-week range
TVRD stock today
On Oct 8, TVRD is trading at $1.05, shedding $0.05 (4.55%), versus the S&P 500's 0.66% decline. At this level, TVRD sits near the bottom of its 52-week range of $0.93 to $43.65: 97.6% below the high, set on Oct 10, 2025 and 12.9% above the low. TVRD is down 74.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 97.3%.
Tvardi Therapeutics has posted a net loss over the last twelve months (EPS of -$2.84), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Tvardi Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2014
Tvardi Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| KPTIKaryopharm Therapeutics Inc. | 0.617 | -4.34% | $13.99M | vs TVRD |
| DAREDare Bioscience Inc. | 0.7575 | -4.11% | $14.90M | vs TVRD |
| HINDVyome Holdings Inc. | 1.98 | -2.94% | $13.90M | vs TVRD |
| KTTAPasithea Therapeutics Corp. | 0.4507 | +1.65% | $15.06M | vs TVRD |
| ALLRAllarity Therapeutics Inc. | 0.9642 | -2.01% | $15.34M | vs TVRD |
| BFRIBiofrontera Inc. | 0.9053 | -3.22% | $13.45M | vs TVRD |
| CTXRCitius Pharmaceuticals Inc. | 0.4849 | -3.23% | $13.31M | vs TVRD |
| CLRBCellectar Biosciences Inc. | 1.39 | -7.95% | $13.14M | vs TVRD |
Indexes, lists and sector
Tvardi Therapeutics stock FAQ
What is Tvardi Therapeutics's stock price today?
TVRD last traded at $1.05 as of Oct 8, 12:58 PM EDT, down 4.55% on the day. Prices are delayed at least 15 minutes.
Does Tvardi Therapeutics pay a dividend?
No. Tvardi Therapeutics does not currently pay a regular cash dividend.
Has TVRD ever split its stock?
Yes. The most recent TVRD stock split was a 1-for-3 split on Apr 16, 2025, one of 2 splits on record.
What is the TVRD 52-week high?
The 52-week high for TVRD is $43.65 and the 52-week low is $0.93. The stock is currently 97.6% below its high.